Literature DB >> 1453233

Absorption and metabolism of pyridoxamine in mice. II. Transformation of pyridoxamine to pyridoxal in intestinal tissues.

T Sakurai1, T Asakura, A Mizuno, M Matsuda.   

Abstract

The absorption of pyridoxamine from the intestine of the mouse was studied in whole animals. [3H]Pyridoxamine was orally administered and the distribution of isotope between the six recognized forms of vitamin B6 was determined in portal blood after the administration. When small doses (1.4 or 14 nmol) were administered, labeled pyridoxamine could hardly be found in the portal blood, although labeled pyridoxal and pyridoxal phosphate were found in the same blood. However, when a large amount (46 or 140 nmol) was given, a significant amount of labeled pyridoxamine was found with labeled pyridoxal and pyridoxal phosphate in the portal blood. These results suggest that a physiological dose of pyridoxamine is rapidly transformed to pyridoxal in the intestinal tissues and then released in the form of pyridoxal into the portal blood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1453233     DOI: 10.3177/jnsv.38.227

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  4 in total

1.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2019-10-31       Impact factor: 9.941

2.  Purification and properties of pyridoxal kinase from bovine brain.

Authors:  T Hirakawa-Sakurai; K Ohkawa; M Matsuda
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

3.  Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.

Authors:  Suzan Wetzels; Kristiaan Wouters; Toshio Miyata; Jean L J M Scheijen; Jerome J A Hendriks; Casper G Schalkwijk; Tim Vanmierlo
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

4.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.